ISO 7101 Service Design: 9 Essential Marks of Control

Clause 8.7, In Practice

Design. Verify. Prove.

ISO 7101 service design is the requirement at Clause 8.7 of ISO 7101:2023 that a healthcare organization control how it designs the services it delivers — the clinical pathways, care bundles, order sets, and standardized protocols that turn published evidence into what actually happens at the bedside. It is the clause most healthcare organizations read once, recognize as sensible, and then satisfy with a document that describes their committee structure rather than controlling their design work.

That gap is the subject of this guide. A pathway is a designed object. It has inputs, outputs, a verification question, and a moment where it goes live and affects real patients. ISO 7101 service design asks the organization to control that sequence deliberately, and nine marks separate a procedure that does it from a procedure that only says it does.

Direct Answer

What is ISO 7101 service design? ISO 7101 service design is the Clause 8.7 requirement that a healthcare organization establish and control a process for designing its services. In practice the designed outputs are clinical pathways, care bundles, order sets, referral routes, and standardized protocols. The clause asks for planning, defined inputs, controls over the design activity, defined outputs, and control of changes — the same control structure applied to product design in other sectors, with clinical evidence taking the place of customer requirements and live care taking the place of a validation laboratory.

What You Will Gain

Key Takeaways on ISO 7101 Service Design

Placement. Control. Currency.

  • Clause 8.7 places ISO 7101 service design inside Clause 8 Operation — between emerging technologies at 8.6 and externally provided services at 8.8, with provision of services at 8.9 immediately after. That placement is an argument about what the clause is for.
  • Nine marks separate a working ISO 7101 service design procedure from one that restates the clause and leaves every hard decision to whoever picks up the work.
  • Healthcare needs one control no manufacturing sector requires: a recurring check that the clinical evidence underneath an active pathway is still current.
  • A designed pathway is validated on patients, not in a laboratory — which makes pilot design with defined stopping rules part of the control structure rather than a nicety.
  • Many health systems hold ISO 9001 for corporate and support services while clinical service design sits outside the management system entirely. ISO 7101 exists to close that gap.
  • Service design under ISO 7101 is not design thinking. The methods can coexist, but the standard asks for control and evidence, not workshops and personas.

Where The Clause Sits

Reading Clause 8.7: What ISO 7101 Service Design Sits Between

Neighbors. Sequence. Intent.

Standards are read clause by clause, which hides something useful. ISO 7101 places its ten Clause 8 requirements in a deliberate order, and the neighbors of Clause 8.7 tell you what the drafters intended ISO 7101 service design to be.

Clause Requirement What the Adjacency Signals
8.6 Emerging technologies New capability arrives here — and has to be designed into a service before it reaches patients
8.7 Service design in healthcare The control point between having a capability and delivering it
8.8 Supplies and services from external providers Designed services frequently depend on external inputs that must be controlled too
8.9 Provision of services Delivery comes immediately after design — the handoff is the point
8.10 People-centred care The design has to serve the person, not the process

Read together, the sequence makes a claim. ISO 7101 service design is an operational control adjacent to delivery — not a strategic planning activity that lives with the improvement team. It sits one clause upstream of provision of services because the drafters expected a designed service to be handed over to delivery in a controlled way, with the same discipline a manufacturer applies when a product leaves engineering for production.

Clause 8.7 does not sit near strategy. It sits one step before delivery. That placement is the whole instruction: design what you are about to do to patients, then hand it over deliberately.

Direct Answer

Where does service design sit in the ISO 7101 clause structure? ISO 7101 service design is Clause 8.7, inside Clause 8 Operation. Its immediate neighbors are emerging technologies at 8.6, supplies and services from external providers at 8.8, provision of services at 8.9, and people-centred care at 8.10. The placement matters: the standard treats service design as an operational control positioned immediately upstream of delivery, rather than as a strategic or improvement activity. Organizations that file the requirement with their improvement programme rather than their operational controls usually end up with a procedure that describes committees instead of controlling design.


What Gets Designed

What ISO 7101 Service Design Actually Governs

Pathways. Bundles. Protocols.

The first practical question in any ISO 7101 service design procedure is what counts as a designed service. Organizations that leave this undefined either apply the control to nothing or apply it to everything, and both failures look identical in an audit: no records.

The designed outputs in a healthcare organization are the artifacts that translate evidence into standardized practice. That typically means clinical pathways and care bundles, standing orders and order sets, referral and escalation routes, discharge and transition-of-care processes, triage and assessment protocols, patient education and consent materials, and the service models around new clinics, new sites, or new modes of delivery such as remote consultation.

What ISO 7101 service design does not govern is individual clinical judgment. A procedure that tries to control how a clinician thinks will be ignored, and rightly. The object of control is the standardized artifact, not the decision a clinician makes within it — the same principle that governs any effective ISO procedure written for expert work.

The trigger question. Write this into the procedure and most scope arguments disappear: does this change what a competent clinician will do in a defined situation, without them exercising fresh judgment? If yes, it is a designed service and Clause 8.7 applies. If it changes only who does it, when, or where, it is a change to service provision under Clause 8.9. Organizations that skip this test end up designing nothing formally and changing everything informally.


The Framework

The 9 Essential Marks of Control in ISO 7101 Service Design

Trigger. Trace. Verify.

Most documents sold or drafted as an ISO 7101 service design procedure are outlines — the shape of a process with the difficult decisions left blank for the buyer to fill in. A working procedure is the opposite: a set of decisions already made and written down, so that the person under pressure on a Thursday afternoon does not have to make them alone.

These nine marks are what MSI looks for when assessing whether an ISO 7101 service design process will hold. They are cumulative — each one depends on the ones above it, and a weakness early in the list guarantees weakness later.

Mark 1

A named trigger, with an owner and a clock. Every route by which a service design activity can begin — a new guideline, a new technology, an incident, a commissioning change, a service expansion, a supplier change — named explicitly, each with a person who owns the decision and a stated timeframe for making it. Without this, ISO 7101 service design runs only when someone senior happens to notice. The most common audit finding here is not an absent trigger; it is a trigger with no owner, which behaves exactly like no trigger at all.

Mark 2

Design inputs traced to a dated clinical evidence source. Each design input recorded against the guideline, systematic review, specialty society recommendation, regulatory requirement, or local epidemiological finding it came from — with the date of that source captured alongside it. This is the mark that makes everything downstream possible, and it is the one most often skipped because the evidence feels obvious to the people in the room. Undated inputs cannot be reviewed for currency later, which quietly disables the ninth mark.

Mark 3

An ambiguity screen on every pathway step. A defined check that each step can be executed by a competent clinician without fresh interpretation. Steps containing words such as promptly, as appropriate, consider, or if clinically indicated fail the screen unless the procedure defines them locally. In manufacturing an ambiguous specification produces a nonconformity found at inspection. In healthcare it is resolved at the bedside, at pace, by whoever is holding it — which is why this mark carries more weight in ISO 7101 service design than in any product standard.

Mark 4

Patient safety controls linked to specific, auditable steps. Every identified safety risk traced to the exact pathway step that controls it. A risk assessment that lives only in a risk register and never became a step in the pathway is a control that will not be delivered, will not be verified, and will not survive staff turnover. This is the point where the organization's risk process and its ISO 7101 service design process have to physically connect rather than merely cross-reference each other.

Mark 5

A design review with real authority and a recorded issue log. A defined review point with named participants, an approval authority that can genuinely stop a rollout, and a record of the substantive issues raised — not merely attendance and a signature. A clinical governance committee that has never declined a pathway is not exercising authority. The record should show what was challenged, what changed as a result, and what was accepted with rationale.

Mark 6

Verification before exposure — peer review and a bounded pilot. Confirmation that the designed pathway does what the inputs required, obtained before it reaches the whole patient population. In practice this means structured peer review plus a limited pilot with a defined population, a defined duration, defined success criteria, and defined stopping rules agreed in advance. The stopping rules are the part organizations skip, and they are the part that makes a pilot a control rather than a soft launch.

Mark 7

Go-live readiness criteria, defined before the go-live decision. A stated list of what must be complete before a designed service is delivered at scale: staff training and competency sign-off, documentation and record templates updated, equipment and consumables available, information systems configured, escalation routes live, and the measurement plan running. Written before the decision, this list is a control. Assembled afterwards, it is a retrospective justification.

Mark 8

Change control after go-live, with an amendment clock. A defined route for amending a live pathway, with the same review discipline as the original design and a record of how many amendments arrive in the first ninety days. Healthcare organizations are unusually prone to informal amendment — a consultant adjusts an order set, a ward adopts a local variation — and an ISO 7101 service design procedure that has no amendment route will simply be bypassed rather than followed.

Mark 9

A recurring evidence currency review. A scheduled re-check of whether the clinical evidence underneath each active pathway is still current, with a defined interval and a named owner. This is the mark with no equivalent in any manufacturing standard, and it is the one that distinguishes a mature ISO 7101 service design process from a competent one. Nothing about a pathway changes when a guideline is superseded — it simply becomes wrong, silently, while continuing to be followed exactly as designed.

Direct Answer

What are the essential marks of a working ISO 7101 service design procedure? Nine: a named trigger with an owner and a clock; design inputs traced to a dated clinical evidence source; an ambiguity screen on every pathway step; patient safety controls linked to specific auditable steps; a design review with genuine authority and a recorded issue log; verification before exposure through peer review and a bounded pilot with stopping rules; go-live readiness criteria defined before the go-live decision; change control after go-live with an amendment clock; and a recurring evidence currency review. They are cumulative — a weakness in the early marks guarantees weakness in the later ones.


The Mark Nobody Writes

Evidence Currency: The Control Healthcare Needs and Manufacturing Does Not

Silent. Gradual. Dangerous.

Every failure mode in a designed product announces itself. A component fails, a specification is missed, a test result comes back out of tolerance. Healthcare carries one that announces nothing at all, and it is the strongest argument for treating ISO 7101 service design as a live process rather than a project.

A guideline is updated. A systematic review is superseded. A drug is reclassified, a resistance pattern shifts, a national recommendation changes its threshold. The pathway does not change. Nobody edits it, nobody breaks it, no incident is reported. It continues to be followed exactly as designed — and it is now wrong. The organization's compliance with its own procedure is perfect, and its care is drifting away from best practice by the month.

A manufactured product does not become non-conforming because the literature moved. A care pathway does. That single asymmetry is why healthcare needs a control no factory has ever required.

Building the Control

  • Date every input at the source. Capture the publication or revision date of each evidence source at the moment the design input is written. Retrofitting dates onto an existing pathway library is significantly harder than capturing them once.
  • Set the interval by volatility, not by convenience. An antimicrobial pathway and a fracture-management pathway do not age at the same rate. Assign each pathway a review interval based on how fast its evidence base moves, rather than putting everything on an annual cycle.
  • Name an owner per pathway, not per programme. A quality department cannot judge whether a specialty guideline has been superseded. The clinical owner can, in minutes.
  • Subscribe to the source, not to the summary. Where a pathway rests on a named guideline body, register for its update notifications so the trigger arrives rather than being discovered.
  • Measure the currency rate. Track the percentage of active pathways whose evidence base has been reviewed within its assigned interval, and report it to management review. It is the single most revealing number in an ISO 7101 service design programme, and almost nobody tracks it.

Direct Answer

How often should ISO 7101 service design pathways be reviewed? Set the interval per pathway according to how quickly its clinical evidence base moves, rather than putting the whole library on one annual cycle. Antimicrobial and oncology pathways age far faster than fracture management or routine screening. Assign a clinical owner to each pathway who can judge whether a guideline has been superseded, register for update notifications from the source bodies the pathway rests on, and report an evidence currency rate — the share of active pathways reviewed within their assigned interval — to management review.


A Common Misreading

ISO 7101 Service Design Is Not Design Thinking

Different. Compatible. Not Interchangeable.

Healthcare has adopted service design as a discipline over the past decade — Double Diamond processes, journey mapping, co-design workshops, personas, experience-based design. It is genuinely valuable work, and it is not what Clause 8.7 asks for. Confusing the two is the most common reason an ISO 7101 service design procedure fails its first audit.

Dimension Service Design as a Discipline ISO 7101 Service Design, Clause 8.7
Primary question What should this service be? Is the design of this service controlled and evidenced?
Typical output Journey maps, concepts, prototypes, blueprints Approved pathways with traceable inputs, verification, and change control
Success measure Improved experience and adoption Demonstrable control, current evidence, and records that survive sampling
Relationship Generates strong design inputs Governs what happens to them afterwards

The productive framing is that design thinking is an excellent method for producing design inputs, and ISO 7101 service design is the control structure that carries those inputs through to verified, current, delivered practice. An organization running co-design workshops with no traceability has ideas. An organization running Clause 8.7 with no user involvement has control over a service nobody wanted. The two are complements, and the standard is silent on method precisely so that an organization can choose its own.

Direct Answer

Is ISO 7101 service design the same as service design thinking? No. Service design as a discipline — journey mapping, co-design, Double Diamond — answers what a service should be. ISO 7101 service design at Clause 8.7 asks whether the design of that service is controlled, evidenced, verified, and kept current. They are complements rather than alternatives: design thinking methods generate strong design inputs, and Clause 8.7 governs what happens to those inputs afterwards. The standard deliberately does not prescribe a design method, which leaves organizations free to use whichever they prefer.


The Handoff

From ISO 7101 Service Design to Clause 8.9: Controlling the Handover

Handover. Evidence. Ownership.

Manufacturing has a name for the moment a design leaves engineering and becomes production's responsibility: design transfer. It is one of the most heavily audited stages in any regulated product sector, because it is where an unfinished design gets absorbed into daily operations and stops being visible as a design problem. Healthcare has the same moment and mostly has no name for it.

The clause sequence points straight at it. ISO 7101 service design at 8.7 is followed immediately by provision of services at 8.9, and the transition between them is where most designed pathways quietly lose their integrity. A pathway approved in committee arrives on a ward where the training has not happened, the order set has not been configured, the escalation number rings to a post that no longer exists, and the staff who will use it were not part of the design. It is still, formally, the approved pathway. It is not what anybody is doing.

Every organization can name the day a pathway was approved. Very few can name the day it was actually in use as designed. The distance between those two dates is where ISO 7101 service design either holds or fails.

What a Controlled Handover Requires

  • A named receiving owner. Someone in the delivery structure formally accepts the pathway, rather than it simply being circulated. Acceptance without a named acceptor is publication.
  • Competency confirmed, not training delivered. An attendance record proves a session happened. ISO 7101 service design handover should evidence that the people who will run the pathway can run it.
  • Systems configured before go-live, not after. Order sets, documentation templates, and electronic record fields aligned to the designed pathway ahead of the first patient rather than during the first month.
  • Escalation routes tested. Ring the number. Page the role. A pathway whose escalation step points to a decommissioned post is a control that exists only on paper.
  • The measurement plan already running. Baseline data captured before go-live, so the organization can tell afterwards whether anything changed.

Direct Answer

How does ISO 7101 service design connect to provision of services at Clause 8.9? Clause 8.7 designs the service and Clause 8.9 delivers it, and the handover between them is the healthcare equivalent of design transfer in a manufacturing sector. A controlled handover needs a named receiving owner in the delivery structure, confirmed competency rather than delivered training, information systems configured before go-live, tested escalation routes, and a measurement plan already capturing baseline data. Organizations that treat approval as the end of ISO 7101 service design consistently find the delivered pathway differs from the designed one within weeks.

The measure that exposes a weak handover is the amendment count in the first ninety days. A pathway generating a stream of early amendments did not need better design review — it needed a controlled handover, and the amendments are the delivery structure retrofitting what should have been settled before go-live. MSI's guide to production and service provision covers the Clause 8.9 side of that boundary in full.


The Scope Gap

Why ISO 9001 Certification Often Leaves Clinical Design Uncovered

Corporate. Clinical. Disconnected.

A pattern shows up repeatedly in health systems that already hold ISO certification. The certificate covers corporate and support functions — facilities, procurement, information services, sometimes laboratory operations — and the management system genuinely works there. Clinical service design sits outside the scope entirely, governed by clinical governance committees that answer to a different structure and produce a different kind of record.

This is not negligence. It is what happens when a general management standard is applied to an organization whose core work is clinical. ISO 9001 permits design and development to be excluded from scope where it does not apply, and a hospital's ISO 9001 scope was frequently written by people whose remit stopped at the ward door. ISO 7101 exists precisely because healthcare needed a standard whose operation clause was written for care rather than for production, and ISO 7101 service design is the clause that closes this particular hole.

Direct Answer

Does ISO 9001 certification cover clinical service design? Usually not. ISO 9001 permits design and development to be excluded from scope where it does not apply, and hospital certification scopes have commonly been drawn around corporate and support functions with clinical work outside them. ISO 7101 service design is the clause written to close that gap, because ISO 7101's operation clause was drafted for care delivery rather than production. The diagnostic question is who approved your last new clinical pathway, and whether that approval appears anywhere in your management system records.

The diagnostic question for any health system already certified. Ask who approved your last new clinical pathway, and then ask whether that approval appears anywhere in your management system records. In most certified health systems the answer to the first question is a clinical governance committee and the answer to the second is no. That is the gap ISO 7101 service design is designed to close — and closing it usually costs less than executives expect, because the governance activity already exists and simply has never been connected to the management system.

For organizations weighing a wider scope, MSI's guide to multi-site ISO certification covers how central-function control maps onto system-level quality leadership, and the harmonized structure across five standards explains why an organization already fluent in ISO 9001 can absorb ISO 7101 faster than it expects.


Proving It Works

Measuring ISO 7101 Service Design

Measure. Trend. Decide.

Marks of control describe what the procedure must contain. They do not tell leadership whether the process is working. That requires measurement, and the measurement framework transfers cleanly from other design-controlled sectors: input integrity, traceability, and readiness at handover, with healthcare adding evidence currency as a tenth measure.

MSI's guide to design control metrics sets out the nine-measure framework in full and includes a healthcare translation table, so it is not repeated here. The short version for an ISO 7101 service design programme is four numbers worth reporting to management review from the start.

  • Protocol revision rate after approval. How much a pathway changes after clinical governance signed it off. Sustained churn means the design inputs were never resolved.
  • Issues raised per design review. Reviews producing zero recorded issues are ceremonial, whatever the attendance record says.
  • Amendments within ninety days of go-live. The clearest signal that a pathway went live before it was finished.
  • Evidence currency rate. The share of active pathways reviewed within their assigned interval — the measure unique to healthcare and the one that ages worst if ignored.

All four belong in management review alongside incidents, complaints, and audit results, where leadership can commit the resources that fix the underlying causes. MSI's ISO management review training covers building a review that produces decisions rather than a slide deck, and its internal audit practice tests the same chains these measures track.


Put It Into Practice

Build the ISO 7101 Service Design Process

Draft. Control. Certify.

Nine marks are straightforward to describe and slow to draft from a blank page, particularly for a clinical governance team already running at capacity. The procedure is where the marks become real, and it is the artifact an auditor asks for first.

Start with the procedure itself. MSI's ISO 7101 Service Design Procedure Template and Guide is a complete, editable Clause 8.7 procedure with the trigger definitions, evidence traceability structure, review authority, pilot and stopping-rule framework, and go-live readiness criteria already written — the judgment calls made, so your team adapts rather than drafts.

Standing up the whole healthcare quality management system? The ISO 7101:2023 Procedure Template and Guide packet covers the full procedure set rather than service design alone — the faster route for organizations starting without a documented system.

Need leadership aligned before the work starts? The Executive ISO 7101 HealthCare Quality Launch Program gives hospital and health system leadership the launch plan for a healthcare quality management system, and the ISO Executive Decision Briefs let executives watch the decisions only leadership can make before implementation begins.

Prefer to talk it through? Schedule a planning session with an MSI consultant at 760-434-9141. MSI's ISO consulting practice brings 28 years of experience, 80+ certifications supported, 200+ audits attended, and 600+ professionals trained across manufacturing, technology, medical device, government, healthcare, and other regulated industries. For organizations that want the system built rather than assembled, SurePath turnkey certification covers implementation end to end.


Go Deeper

Related Reading on ISO 7101 and Healthcare Quality

Context. Method. Practice.


Common Questions

Frequently Asked Questions About ISO 7101 Service Design

Ask. Answer. Apply.

What is ISO 7101 service design?

ISO 7101 service design is the Clause 8.7 requirement that a healthcare organization control how it designs the services it delivers. The designed outputs are clinical pathways, care bundles, order sets, referral and escalation routes, and standardized protocols. The clause asks for planning, defined inputs, controls over the design activity, defined outputs, and control of changes — clinical evidence taking the place of customer requirements, and live care taking the place of a validation laboratory.

Which ISO 7101 clause covers service design?

Clause 8.7, Service Design in Healthcare, within Clause 8 Operation. Its neighbors are emerging technologies at 8.6, supplies and services from external providers at 8.8, provision of services at 8.9, and people-centred care at 8.10. That placement is meaningful — ISO 7101 treats service design as an operational control positioned immediately upstream of delivery rather than as a strategic or improvement activity.

What counts as a designed service under ISO 7101?

Apply this test: does the artifact change what a competent clinician will do in a defined situation, without them exercising fresh judgment? Clinical pathways, care bundles, standing orders and order sets, triage and assessment protocols, referral and escalation routes, discharge and transition processes, patient education materials, and new service models all pass. Changes to who delivers a service, when, or where are changes to service provision under Clause 8.9 rather than design under 8.7.

Does ISO 7101 service design control clinical judgment?

No, and a procedure that tries will be ignored. The object of control is the standardized artifact — the pathway, the protocol, the order set — not the decision a clinician makes within it. The discipline is to control the controls rather than the clinical reasoning, which is the same principle that governs any procedure written for expert work in any sector.

What is an evidence currency review and why does healthcare need one?

An evidence currency review is a scheduled re-check of whether the clinical evidence underneath an active pathway is still current, with a defined interval and a named clinical owner. Healthcare needs it because of a failure mode with no manufacturing equivalent: when a guideline is superseded, nothing about the pathway changes. It is not broken, no incident is raised, and it continues to be followed exactly as designed while quietly becoming wrong. Intervals should be set by how fast each pathway's evidence base moves rather than on a single annual cycle.

Is ISO 7101 service design the same as design thinking or co-design?

No. Design thinking methods — journey mapping, co-design, Double Diamond — answer what a service should be. Clause 8.7 asks whether the design of that service is controlled, evidenced, verified, and kept current. The two are complements: design thinking generates strong design inputs, and ISO 7101 service design governs what happens to those inputs afterwards. The standard prescribes no design method, which leaves organizations free to choose.

Our hospital already holds ISO 9001. Does that cover clinical service design?

Usually not. ISO 9001 permits design and development to be excluded from scope where it does not apply, and hospital scopes have frequently been written around corporate and support functions — facilities, procurement, information services — with clinical work outside. The diagnostic question is simple: who approved your last new clinical pathway, and does that approval appear anywhere in your management system records? In most certified health systems the answers are a clinical governance committee, and no.

How do you verify a clinical pathway before it goes live?

Through structured peer review plus a bounded pilot — a defined patient population, a defined duration, defined success criteria, and stopping rules agreed before the pilot starts. The stopping rules are what make it a control rather than a soft launch, and they are the element organizations most often omit. Healthcare cannot validate a design in a laboratory the way a manufacturer can, which puts more weight on verification before broad exposure.


The Bottom Line

Make ISO 7101 Service Design a Control, Not a Committee

Design. Verify. Sustain.

Healthcare organizations rarely lack governance. They have committees, minutes, approvals, and sign-offs in abundance. What they frequently lack is a control structure that connects a piece of published evidence to a step a clinician performs, and keeps that connection current as the evidence moves underneath it.

That is the whole of ISO 7101 service design. Nine marks build the structure — a trigger with an owner, inputs traced to dated evidence, an ambiguity screen, safety controls landed on real steps, a review with authority, verification before exposure, readiness criteria written in advance, an amendment route, and a recurring currency check. The tenth thing, measurement, is how leadership finds out whether any of it is working.

Clause 8.7 sits one step before delivery for a reason. Design what you are about to do to patients, prove it does what the evidence required, hand it over deliberately — and then keep checking that it is still true.

A pathway that is followed perfectly and is three guidelines out of date is not a compliance success. It is a silent failure with excellent records.


References & Sources

International Organization for Standardization. ISO 7101:2023 — Healthcare organization management: management systems for quality. www.iso.org/standard/82069.html

International Organization for Standardization. ISO 9001 — Quality management systems. www.iso.org/iso-9001-quality-management.html

International Organization for Standardization. ISO/TC 304 — Healthcare organization management. www.iso.org/committee/4266138.html

International Organization for Standardization. ISO 31000 — Risk management. www.iso.org/iso-31000-risk-management.html

International Organization for Standardization. ISO 45001 — Occupational health and safety management systems. www.iso.org/standard/63787.html

World Health Organization. Quality of care. www.who.int/health-topics/quality-of-care

World Health Organization. Patient safety. www.who.int/health-topics/patient-safety

Agency for Healthcare Research and Quality. Clinical guidelines and evidence resources. www.ahrq.gov/

Agency for Healthcare Research and Quality. Patient Safety Network. psnet.ahrq.gov/

Institute for Healthcare Improvement. Improvement science and care model resources. www.ihi.org/

National Institute for Health and Care Excellence. NICE guidance and quality standards. www.nice.org.uk/

Cochrane. Cochrane Library of systematic reviews. www.cochranelibrary.com/

National Academy of Medicine. Quality and health system publications. nam.edu/

Centers for Medicare & Medicaid Services. Quality measurement and reporting programs. www.cms.gov/

The Joint Commission. Accreditation standards and patient safety goals. www.jointcommission.org/

Global Accreditation Cooperation International. Accreditation body directory and recognition arrangements. global-aci.org/

American Society for Quality. Failure Mode and Effects Analysis (FMEA). asq.org/quality-resources/fmea

American Society for Quality. Five Whys. asq.org/quality-resources/five-whys

About Management Systems International (MSI)

Management Systems International (MSI) is a veteran-owned, female-owned ISO consulting firm founded in 1998. With 28 years of experience including extensive AS9100 work in MSI's early years, MSI's track record includes 80+ certifications supported, 200+ audits attended, and 600+ professionals trained across manufacturing, technology, medical device, government, healthcare, and other regulated industries.

Today MSI implements ISO 9001, ISO 13485, ISO 14001, and ISO 45001, with an expanding focus on ISO 7101 healthcare quality.

msi-international.com  ·  760-434-9141

Share this post:
post by:
Picture of Diana Lynn

Diana Lynn

Founder and Principal of Management Systems International (MSI), a veteran-owned, female-owned ISO consulting firm she founded in 1998. Diana implements management systems, conducts audits, and develops MSI's entire training curriculum — 80+ organizations certified, 200+ audits, and 600+ professionals trained across manufacturing, technology, aerospace, medical device, government, healthcare, defense, and other regulated industries.
In This Guide
Stay Informed

Join our early-access list for ISO 14001:2026 briefings.

Trusted by Global Leaders

Don't miss our latest news!

Get on our Email list. MSI emails new offers, training dates, and ISO updates to our list before anyone else.

Twenty-eight years of practice, written down.
New: complete ISO procedure templates and guides. 13 procedure topics, five standards and combos, editable Word — with the judgment calls already made.
See the templates →

Buy any Template Packages and the price is credited 100% to ISO Consulting Projects, SurePath or SureResults Online or Traditional. Terms apply